Targeting Ion Channels in Drug Discovery
Video
Published: December 9, 2019
|
Last Updated: February 21, 2024
|
Marc Rogers, PhD
Founding Director, Albion Drug Discovery Services
Marc is a trained neuroscientist with 30 years of experience using patch clamp and imaging techniques to study ion channel function and modulation. He was an early adopter of automated patch clamp platforms for ion channel screening and has an excellent knowledge of this market and extensive connections with users and vendors. Marc co-founded several ion channel companies, before setting up his consultancy company Albion Drug Discovery Services.
Learn about our editorial policies
Marc Rogers, Metrion Biosciences, outlines the benefits of targeting ion channels for pain and some of the hurdles in developing successful ion channel modulators.
Meet the Author
Founding Director, Albion Drug Discovery Services
Marc is a trained neuroscientist with 30 years of experience using patch clamp and imaging techniques to study ion channel function and modulation. He was an early adopter of automated patch clamp platforms for ion channel screening and has an excellent knowledge of this market and extensive connections with users and vendors. Marc co-founded several ion channel companies, before setting up his consultancy company Albion Drug Discovery Services.
Advertisement
Chosen for You